Measures of treatment efficacy
P P Hujoel1, D A Baab, T A DeRouen
1Department of Dental Public Health Sciences, School of Dentistry, University of Washington, Seattle 98195.
Journal of Clinical Periodontology
|September 1, 1993
Summary
This study evaluates periodontal treatment efficacy measures, highlighting limitations of mean differences. It compares relative risk, P-values, risk difference, and preventable fraction for better clinical outcome interpretation.
Area of Science:
- Periodontal research
- Biostatistics
- Clinical trial analysis
Background:
- Traditional periodontal research relies on mean differences for treatment efficacy.
- This measure often fails to convey clinical relevance, frustrating clinicians and researchers.
- Interpreting small mean differences (e.g., 0.4 mm) poses challenges in clinical decision-making.
Purpose of the Study:
- To compare various measures of treatment efficacy in periodontal research.
- To identify more effective ways to communicate treatment outcomes and clinical relevance.
- To guide clinicians and researchers in selecting appropriate efficacy metrics.
Main Methods:
- Comparative analysis of different statistical measures for treatment efficacy.
- Evaluation of mean difference, relative risk, significance levels (P-values), risk difference, and preventable fraction.
- Discussion of advantages and disadvantages of each measure in the context of periodontal outcomes.
Main Results:
- Mean difference lacks clarity in communicating the clinical significance of periodontal treatment outcomes.
- Alternative measures like relative risk and risk difference may offer better insights into treatment impact.
- Significance levels (P-values) indicate statistical significance but not necessarily clinical relevance.
Conclusions:
- The limitations of mean difference in periodontal research necessitate exploring alternative efficacy measures.
- Relative risk, risk difference, and preventable fraction offer more interpretable data for clinical decision-making.
- Adopting a broader range of statistical tools can enhance the understanding and application of treatment efficacy in periodontology.
More Related Videos
Related Concept Videos
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...